Sterling Accuris Expands in Ahmedabad with Gujarat Pathology Acquisition
Ahmedabad, April 16, 2025: Sterling Accuris Diagnostics, one of India’s fastest-growing NABL-accredited pathology lab chains, has announced the acquisition of Gujarat & Maha Gujarat Pathology Laboratories — a well-known diagnostic service provider in Ahmedabad. This move will help Sterling Accuris expand its reach across the city and improve the quality and accessibility of its diagnostic services.
Sterling Accuris is known for its patient-focused approach and ethical diagnostic services. It offers accurate and trustworthy pathology solutions for individuals, hospitals, and businesses. Gujarat Pathology Laboratory, which has been operating since 1998, provides a wide range of tests including Hematology, Biochemistry, Immunology, and Molecular Biology. With 8 labs and over 20 collection centres in Ahmedabad, it has served nearly 2 million patients over the years.
Mr. Rajiv Sharma, Managing Director of Sterling Accuris, said, “Gujarat Pathology Laboratory has earned a solid reputation over 27 years in Ahmedabad. This acquisition helps us serve more patients and strengthens our presence in the B2C segment. Together, we can offer better services and wider coverage across Ahmedabad and Gujarat.”
Mr. Ankush Gupta, CEO of Sterling Accuris, added, “India’s diagnostic market is growing quickly. The pathology segment is expected to grow at 14% annually from 2025 to 2030. This is our fourth acquisition in two years and a key part of our growth strategy. We believe this will take Sterling Accuris to the next level.”
Dr. Niraj Kothari and Mr. Vishnubhai Patel, Founders of Gujarat Pathology Laboratory, along with Mr. Navinbhai Patel, Founder of Maha Gujarat Pathology Laboratory, welcomed the partnership. They shared, “Joining hands with Sterling Accuris allows us to upgrade our services using advanced technology. This collaboration will help us offer a wider range of tests and reach more people in and around Ahmedabad.”
Since starting in 2015, Sterling Accuris has seen rapid growth, now operating over 75 labs and 300+ collection centres across India. The company focuses on patient-friendly services through multilingual chatbots, easy-to-use mobile apps, informative websites, and a modern customer care centre with a dedicated contact point. Sterling Accuris Wellness Private Limited is backed by Morgan Stanley Private Equity Asia, supporting its vision for continued expansion and service excellence.